TrialProstate cancer and prostatic diseases2015

Change in PSA velocity is a predictor of overall survival in men with biochemically-recurrent prostate cancer treated with nonhormonal agents: combined analysis of four phase-2 trials.

D L Suzman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.